Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04892524
Other study ID # SALHNLungNodules
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 19, 2021
Est. completion date October 2023

Study information

Verified date September 2022
Source Southern Adelaide Local Health Network
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a study to determine how a virtual model for the management of lung nodules compares to a face-to-face clinic for patient satisfaction, quality of life and cost.


Description:

Initial Steps: 1. Individuals that have been referred to the Respiratory Outpatient Department of Flinders Medical Centre for management of a lung nodule will have their referral data screened by a doctor to determine that the referral meets criteria for management in the outpatient department and which category of follow-up is required (triaging process). 2. Eligible referrals will be provided to the study's research assistant who will contact the individual to discuss the study in detail and obtain consent to participate. 3. Individuals that have consented to participate are randomly assigned to either the 'virtual model' of lung nodule management (a), or the 'face-to-face model' of lung nodule management (b). Each participant has a 50% chance (1 in 2) of being assigned to either group. 1. The 'virtual model' involves participants' CT scan(s) being reviewed by a multi-disciplinary team of specialist doctors, nurses and radiologists in a virtual environment. The team will analyse these scans and make a recommendation for any follow-up scans, procedures or appointments that may be required. The team will contact each participant with a phone-call. Participants primary care providers will also receive a letter describing the review and plan. Participants are not required to physically attend the hospital or outpatient department for this review to occur. 2. The 'face-to-face model' involves a face-to-face appointment in the Respiratory outpatient clinic at Flinders Medical Centre, where a doctor will review participants' CT scan(s) and make a plan for any follow-up scans, procedures or appointments that may be required. Primary care providers will be informed of the outcome of this visit. Participants are required to physically attend the clinic appointment for this review. All participants in this research study will be asked to complete an initial set of two questionnaires. The questionnaires include: - Participant information questionnaire - collects personal information and contact details, as well as specific health-related, occupational and lifestyle information. - Hospital Anxiety and Depression Scale (HADS) Once participants have had their face-to-face appointment or virtual review, they will be asked to complete four questionnaires at a 1-month and 3-month interval. The questionnaires include: - Hospital Anxiety and Depression Scale (HADS) - Patient experience questionnaire - Patient economic impact questionnaire - Modified Visit-specific satisfaction instrument (VSQ-9)


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 55
Est. completion date October 2023
Est. primary completion date May 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age 18-80 years - At least 1 IPN identified on CT imaging measuring 4-30 mm in maximal diameter - CT slice thickness of 3 mm or less Exclusion Criteria: - Previous diagnosis of lung cancer - History of haemoptysis - Unexplained weight loss > 7 kg in the preceding 12 months - Past history of malignancy within 5 years (excluding non-melanoma skin cancer)

Study Design


Intervention

Other:
Virtual multidisciplinary review
The virtual multidisciplinary review involves participants being reviewed by a multi-disciplinary team of specialist doctors, nurses and radiologists in a virtual environment. The team will analyse radiologic scans and make a recommendations for any follow-up scans, procedures or appointments that may be required

Locations

Country Name City State
Australia Flinders Medical Centre Bedford Park South Australia

Sponsors (1)

Lead Sponsor Collaborator
Southern Adelaide Local Health Network

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cost Economic cost to participants and our health service, measured by an investigator-derived questionnaire asking participants to describe time spent engaging in the their health care and any direct costs associated with visits. Economical modelling will also be applied to determine the staffing and resource costs associated with provision of care to participants in each arm. 6 months
Secondary Participant satisfaction Participant satisfaction, measured by the Visit-Specific Satisfaction Instrument (VSQ-9) 6 months
Secondary Anxiety Participant anxiety as measure by the Hospital Anxiety and Depression Scale (HADS), which is a questionnaire containing seven items each for depression and anxiety subscales. Scoring for each item ranges from zero to three, with three denoting highest anxiety or depression level. A total subscale score of >8 points out of a possible 21 denotes considerable symptoms of anxiety or depression. 6 months
See also
  Status Clinical Trial Phase
Completed NCT03649906 - A Clinical Study of Optimized CT-guided Pulmonary Nodule Microcoil Localization Technique N/A
Completed NCT05963945 - Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice
Completed NCT04066699 - Percutaneous Localization: Open-label Registry of Thoracic Surgery
Not yet recruiting NCT05477251 - Comparative Study on the Efficacy and Safety of Microwave Ablation and Lobectomy in the Treatment of Ground Glass Nodules Located in the Pulmonary Hilar Region N/A
Completed NCT03591445 - Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005) N/A
Withdrawn NCT04894682 - Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Recruiting NCT03790735 - The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules
Active, not recruiting NCT03992183 - Utility of CAML as Diagnostic for Early Stage Lung Cancer
Recruiting NCT04552054 - Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules N/A
Recruiting NCT05389774 - DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
Recruiting NCT06308120 - A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB N/A
Completed NCT04209972 - The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules N/A
Completed NCT03181490 - Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
Recruiting NCT05445635 - Added Value of a Small Camera (Iriscope) in the Endoscopic Diagnosis of Peripheral Lung Nodules and Masses N/A
Recruiting NCT04270799 - Lung Nodule Imaging Biobank for Radiomics and AI Research
Recruiting NCT00841750 - Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection Phase 3
Recruiting NCT05415670 - Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)
Recruiting NCT04005677 - The Early Diagnosis of Pulmonary Nodule Based on Multi-dimension Messages
Recruiting NCT05968898 - Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES N/A
Completed NCT04302350 - Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial N/A